Bordetella holmesii
| Bordetella holmesii | |
|---|---|
| Bordetella holmesii | |
| Scientific classification | |
| Kingdom | |
| Phylum | |
| Class | |
| Order | |
| Family | |
| Genus | Bordetella |
| Species | holmesii |
| Binomial name | Bordetella holmesii |
| Binomial authority | |
| Synonyms | |
Bordetella holmesii is a Gram-negative, rod-shaped bacterium of the genus Bordetella. It was first described by Weyant et al. in 1994 and named in recognition of Barry Holmes, a prominent biologist. This bacterium is part of the family Alcaligenaceae and is closely related to *Bordetella pertussis*, the causative agent of whooping cough.
- B. holmesii* is characterized as asaccharolytic, oxidase-negative, and nonmotile, producing a distinctive brown pigment. Unlike *Bordetella pertussis*, *Bordetella holmesii* does not utilize sugars for energy, which is reflected in its asaccharolytic nature.
Pathogenicity and Clinical Significance[edit]
- Bordetella holmesii* is associated with a variety of infections, particularly in immunocompromised individuals such as those with AIDS or those who are asplenic. It has been implicated in cases of sepsis, endocarditis, and respiratory illness, making it a significant pathogen in certain high-risk groups.
The bacterium has also been found in patients co-infected with *Bordetella pertussis*, although its role in these mixed infections is still under investigation. While *Bordetella holmesii* is not as well studied as *Bordetella pertussis*, it has been reported to cause illness similar to that of other Bordetella species, including symptoms of upper respiratory tract infection and more severe systemic complications in vulnerable individuals.
Diagnosis and Identification[edit]
The identification of *Bordetella holmesii* is typically done through microbiological culture and identification methods. It is important to note that this bacterium shares many similarities with *Bordetella pertussis* and *Bordetella parapertussis*, so differentiation between these species may require advanced techniques such as molecular testing or PCR. The bacterium’s nonmotility, oxidase-negative status, and asaccharolytic nature are distinguishing characteristics.
External Links[edit]
This article is a Betaproteobacteria-related stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian